Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Artificial Intelligence in Revolutionizing Drug Discovery
Ashfaq Ur Rehman, Mingyu Li, Binjian Wu, et al.
Fundamental Research (2024)
Open Access | Times Cited: 24

Showing 24 citing articles:

Challenges and applications of artificial intelligence in infectious diseases and antimicrobial resistance
Angela Cesaro, Samuel C. Hoffman, Payel Das, et al.
npj Antimicrobials and Resistance (2025) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Revolutionizing Prostate Cancer Therapy: Artificial intelligence – based Nanocarriers for Precision Diagnosis and Treatment
Moein Shirzad, Afsaneh Salahvarzi, Sobia Razzaq, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104653-104653
Closed Access | Times Cited: 3
AI-powered drug discovery for neglected diseases: accelerating public health solutions in the developing world
MD Nahid Hassan Nishan
Journal of Global Health (2025) Vol. 15
Open Access | Times Cited: 2
Integrating AI into Cancer Immunotherapy—A Narrative Review of Current Applications and Future Directions
David B. Olawade, Aanuoluwapo Clement David-Olawade, Temitope Adereni, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 24-24
Open Access | Times Cited: 1
Flavonoids and Flavonoid-Based Nanopharmaceuticals as Promising Therapeutic Strategies for Colorectal Cancer—An Updated Literature Review
Andreea Smeu, Iasmina Marcovici, Cristina Dehelean, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 231-231
Open Access | Times Cited: 1
Farmasi Cerdas: Era Baru Penemuan Obat dengan AI dan Big Data
Raymond R. Tjandrawinata
MEDICINUS (2025) Vol. 38, Iss. 1, pp. 27-36
Closed Access
Advancing Cancer Drug Delivery with Nanoparticles: Challenges and Prospects in Mathematical Modeling for In Vivo and In Vitro Systems
Tozivepi Aaron Munyayi, Anine Crous
Cancers (2025) Vol. 17, Iss. 2, pp. 198-198
Open Access
Special Issue “Advances in Drug Discovery and Synthesis”
Lidia Ciccone, Susanna Nencetti
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 584-584
Open Access
Advancements in proteogenomics for preclinical targeted cancer therapy research
Yuying Suo, Yuanli Song, Yuqiu Wang, et al.
Biophysics Reports (2025) Vol. 11, Iss. 1, pp. 56-56
Open Access
Utility of Artificial Intelligence in Antibiotic Development: Accelerating Discovery in the Age of Resistance
Esteban Zavaleta‐Monestel, Carolina Rojas-Chinchilla, Jeimy Campos-Hernández, et al.
Cureus (2025)
Open Access
<b>Memanfaatkan Kecerdasan Buatan dan Pembelajaran Mesin dalam Inovasi Farmasi</b>
Raymond R. Tjandrawinata
MEDICINUS (2025) Vol. 38, Iss. 2, pp. 28-35
Open Access
Deep learning: A game changer in drug design and development
Sushanta Kumar Das, Rahul Mishra, Amit Samanta, et al.
Advances in pharmacology (2025)
Closed Access
Identification and Evaluation of Bioactive Compounds from Azadirachta indica as Potential Inhibitors of DENV-2 Capsid Protein: An Integrative Study Utilizing Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and Machine Learning Techniques.
Md. Ahad Ali Khan, Md. Nazmul Hasan Zilani, Mahedi Hasan, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42594-e42594
Open Access
The Transformative Impact of Artificial Intelligence on Drug Discovery: A Technical Review
Poshan Kumar Reddy Ponnamreddy
International Journal of Scientific Research in Computer Science Engineering and Information Technology (2025) Vol. 11, Iss. 1, pp. 2772-2780
Open Access
Harnessing the power of artificial intelligence for disease-surveillance purposes
Barbara Tornimbene, Zoila Beatriz Leiva Rioja, John S. Brownstein, et al.
BMC Proceedings (2025) Vol. 19, Iss. S4
Open Access
Evaluation of various bioactive molecules for their gp120–CD4 binding inhibitory properties by in-silico molecular docking and dynamic studies
Honey Tank, Niketan Deshmukh
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Embracing the changes and challenges with modern early drug discovery
Vinay Kumar, Kunal Roy
Expert Opinion on Drug Discovery (2025)
Closed Access
Exploring the impact of bioactive peptides from fermented Milk proteins: A review with emphasis on health implications and artificial intelligence integration
Hosam M. Habib, Rania Ismail, Mahmoud Agami, et al.
Food Chemistry (2025), pp. 144047-144047
Closed Access
From past to future: Digital approaches to success of clinical drug trials for Parkinson's disease
Cen Cong, Madison Milne‐Ives, Ananya Ananthakrishnan, et al.
Journal of Parkinson s Disease (2025)
Open Access
From roots to codes: Applications of computer-aided drug discovery from medicinal plants
Amina Javid, Areej Fatima, M Alkahtani Hamad, et al.
South African Journal of Botany (2024) Vol. 173, pp. 159-174
Closed Access | Times Cited: 1
Multidisciplinary Training for Fostering Next-Generation Medicinal Chemists
Bin Yu, Xiaoyun Lu, Junbiao Chang
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 20, pp. 17943-17945
Open Access | Times Cited: 1
Molecular Fingerprints and Pharmacophores for Computational Drug Repurposing
Lina Rozano, Muhammad Irfan Abdul Jalal, Nur Alyaa Afifah Md Shahri, et al.
Elsevier eBooks (2024)
Closed Access
Revolutionizing Pharmaceutical Sciences
Ch. Hima Bindu, Raveendra Babu, Sasidhar Bhimana, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 217-246
Closed Access
Advanced High Throughput Screening Platforms in Drug Discovery
Chinmayi Joshi, Drashti Makwana
Advances in medical technologies and clinical practice book series (2024), pp. 35-74
Closed Access
Page 1

Scroll to top